Pursuant to Executive Order 14222 and recent federal priority shifts towards process optimization, cost-saving, and improved efficiency, this interagency briefing addresses the importance and value of reverse distribution programs in federal healthcare systems. With increased scrutiny from federal agencies towards reverse distribution efforts, the effective management, utilization, and disposal of pharmaceuticals is now a frontline issue.
Using reverse distribution, federal agencies can simultaneously improve compliance, reduce workload, and recover previously lost dollars. This session will explore the regulations around pharmaceutical returns, and present real-world guidance for implementing cost-efficient programs across the federal government.
Recommended Attendees:
- Pharmacy Directors and Compliance Officers
- Facility Procurement Officials
- Administrative Officers
- Federal Logistics and Supply Chain Personnel
- Compliance Review Teams
Important: This briefing uses a Zoom-based communication connection via your network. This briefing will be accessible via phone if you are unable to connect online and recorded versions will be distributed with closed-caption for the hearing impaired. Instructions for login will be provided upon registration.
2 speakers on this recording.
